The store will not work correctly when cookies are disabled.
1-(4-phenylphenyl)sulfonylpyrrolidine-2,5-dione
ID: ALA4859980
PubChem CID: 164617594
Max Phase: Preclinical
Molecular Formula: C16H13NO4S
Molecular Weight: 315.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1CCC(=O)N1S(=O)(=O)c1ccc(-c2ccccc2)cc1
Standard InChI: InChI=1S/C16H13NO4S/c18-15-10-11-16(19)17(15)22(20,21)14-8-6-13(7-9-14)12-4-2-1-3-5-12/h1-9H,10-11H2
Standard InChI Key: KYCWBGVSQSFKED-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
32.6835 -2.1792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.8981 -2.9716 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
33.4771 -2.3895 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.8663 -4.0034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1207 -3.2267 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.4577 -2.7446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4565 -1.9274 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.3459 -4.6651 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.0491 -4.0034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7980 -3.2238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5047 -3.5229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3283 -4.3221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9341 -4.8731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7158 -4.6236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8883 -3.8179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2811 -3.2703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3197 -5.1710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1456 -5.9706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7502 -6.5191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5292 -6.2694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7001 -5.4659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0941 -4.9208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
9 4 1 0
4 5 1 0
5 6 1 0
6 10 1 0
6 7 2 0
4 8 2 0
9 10 1 0
5 2 1 0
2 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
14 17 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 315.35 | Molecular Weight (Monoisotopic): 315.0565 | AlogP: 2.19 | #Rotatable Bonds: 3 |
Polar Surface Area: 71.52 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.25 | CX LogD: 2.25 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.81 | Np Likeness Score: -0.82 |
References
1. Parsons WH, Rutland NT, Crainic JA, Cardozo JM, Chow AS, Andrews CL, Sheehan BK.. (2021) Development of succinimide-based inhibitors for the mitochondrial rhomboid protease PARL., 49 [PMID:34311087] [10.1016/j.bmcl.2021.128290] |